About the Author
Innovation Station guest columnist Dr. Sungwon Lim is the CEO and co-founder of ImpriMed Inc., which uses artificial intelligence on live cancer cell analytics to predict how a dog will respond to cancer therapy drugs before taking them. He earned a doctorate in bioengineering from Stanford University and a master’s degree in translational medicine from the UC Berkeley-UCSF Joint Bioengineering Program.
Written By This Author
